IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?

Mohammad Alsaeid, Osamah Abu Hawi, Talat Bessissow, Peter L. Lakatos

Open source

DOI
10.3390/jcm15124408
Published
2026-06-06
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15124408,
  title = {IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?},
  author = {Mohammad Alsaeid and Osamah Abu Hawi and Talat Bessissow and Peter L. Lakatos},
  year = {2026},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm15124408},
  url = {https://doi.org/10.3390/jcm15124408}
}

RIS

TY  - JOUR
TI  - IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?
AU  - Mohammad Alsaeid
AU  - Osamah Abu Hawi
AU  - Talat Bessissow
AU  - Peter L. Lakatos
PY  - 2026
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15124408
UR  - https://doi.org/10.3390/jcm15124408
ER  - 

APA

Alsaeid, M., Hawi, O. A., Bessissow, T., & Lakatos, P. L. (2026). IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15124408

Source records